Navigation Links
Biomatlante Announces the Appointment of its New CEO
Date:2/2/2019

Biomatlante, a world leader in synthetic bone regeneration technologies, is pleased to announce the appointment of its new CEO, Julien Dert, being effective on February 1st, 2019.

Graduated from ICN Business School, Julien has 25 years of international experience in finance and management, in which more than 12 years in the Medical Device industry. Chief Financial Officer of Biomatlante and member of its Management Committee since 2009, he has worked closely with Chantal Gobin in the development of the company, preserving its capacity of innovation in a challenging competitive and regulatory environment.

"I am extremely honored that Biomatlante's shareholders, especially the founders Chantal Gobin and Guy Daculsi, have put their confidence in me. Chantal and Guy are true visionaries, whose passion for the company will serve as a model for the future," says Julien Dert. "I know Biomatlante very well, and I know I can count on a dynamic and dedicated team to continue to bring the best therapeutic solutions to patients. I am thrilled to have this opportunity to shepherd Biomatlante's continued growth in innovative bone regenerative technologies.”

“Creating a company is a permanent commitment, we have to ensure its development, its sustainability, being surrounded by people with the same values. It is therefore with confidence and pride that I convey the management to Julien," says Chantal Gobin, Chairman of Biomatlante’s Board. “I know he will preserve the DNA of Biomatlante, considering the respect of the human person, the loyalty, the thoroughness, the adhesion to Research and Development, the insurance of a quality policy respecting the regulatory requirements of the medical devices, with the aim of preserving the safety of the patients. As Chairman, it is a great pleasure to support Julien in his new CEO position”.

Read the full story at https://www.prweb.com/releases/biomatlante_announces_the_appointment_of_its_new_ceo/prweb16071643.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. DistinctBright, Probiotic Cleaner, Announces their Probiotic Cleaner is Safe for Pets
2. Annual Conference about Technology Solutions for People with Disabilities Announces Program
3. Probiotic Action Announces Probiotics Lead the Digestive Health Market
4. Verenium Announces Preliminary Financial Results For Fiscal 2012
5. Senomyx Announces Fourth Quarter And Full Year 2012 Financial Results And Initiation Of New Direct Sales Strategy
6. Neuralstem Announces 2012 Financial Results, Provides Clinical Trials Update
7. EAG Announces New General Manager of Release-To-Production (RTP) Division
8. DuPont Tate & Lyle Bio Products Announces Novel Application for Zemea® Propanediol
9. Probiotic Action Announces China’s $5 Billion Dollar Investment in Probiotics
10. EAS Consulting Group, Experts in Quality Regulatory Services Related to FDA Issues, Announces Upcoming Dietary Supplement Seminars in Salt Lake City
11. 3D Biomatrix Announces Stipend to Present at Spring 2013 Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/19/2019)... ... March 19, 2019 , ... Konica Minolta Precision ... the formation of their inaugural Scientific Advisory Board. , Founded in ... into account individual variability in genes, environment, and lifestyle to more accurately predict, ...
(Date:3/19/2019)... ... March 19, 2019 , ... Cirrascale Cloud ... it has begun offering NVIDIA® DGX-1™ deep learning systems as part of its ... provide the highest performance for artificial intelligence and deep learning research and development. ...
(Date:3/14/2019)... ... 2019 , ... EyeCRO LLC has been awarded full accreditation ... Department of Veterans Affairs, the Oklahoma Medical Research Foundation, Oklahoma State University, and ... to receive this prestigious endorsement. The award letter from AAALAC International stated: ...
(Date:3/14/2019)... , ... March 14, 2019 , ... ... release announcing that its Canadian partner, the Eye Machine Canada Inc., had been ... Oculus’s pioneering technology for treating Age-Related Macular Degeneration (AMD). , The previous month, ...
Breaking Biology Technology:
(Date:4/4/2019)... ... 2019 , ... The live session taking place ... connectivity between product risk management (ISO 14971) and the clinical risk management process ... With increasing global regulation and reimbursement challenges faced by medical device companies, it ...
(Date:4/4/2019)... ... April 03, 2019 , ... ... therapies performed at its nationwide Centers of Excellence. R3 wants patients to feel ... provider. , To protect patients from Centers that use inferior regenerative biologics, protocols ...
(Date:4/1/2019)... ... April 01, 2019 , ... Stay on top of current ... and food industries. Access to all webinars is free, so be sure to register ... field! , Visit http://www.xtalks.com to see our upcoming webinars: , CLINICAL TRIALS ...
Breaking Biology News(10 mins):